Medical Online, July 28. In the past 5 years, the compound annual growth rate of pharmaceutical excipients, Chinese patent medicines, and biochemical products were 24.32%, 24.27%, and 31.15% respectively. With the total scale of pharmaceutical excipients expanding year by year, the market demand for pharmaceutical excipients will also increase, and will grow at a rate of 15%-20% per year. Even with a conservative estimate of 15% annual growth, by 2015, the market size of pharmaceutical excipients in China will reach nearly 40 billion yuan, indicating that its growth potential is quite broad.

From the perspective of types of pharmaceutical excipients, the top ten pharmaceutical excipients in the Chinese market by scale are pharmaceutical gelatin capsules, sucrose, starch, film-coating powder, 1,2-propanediol, PVP, hydroxypropyl methylcellulose (HPMC), microcrystalline cellulose, HPC, and lactose. There are about 500 types of excipients in the Chinese market, but compared to the United States (more than 1500 types) and the European Union (more than 3000 types), the variety is still small, indicating that China's pharmaceutical excipient market has huge development potential.

In terms of dosage forms, oral solid excipients are the mainstream of the industry and the fastest growing: In 2005, the market size of pharmaceutical excipients for oral solid dosage forms in the United States, Europe, and China was close to US$800 million, with sales of 225,000 tons; In 2010, the scale of pharmaceutical excipients for oral solid dosage forms in the United States and Europe grew at an average annual rate of 2.3% and 2.6% respectively, while the average annual growth rate in China has reached about 8%.

From the perspective of the proportion of pharmaceutical excipients in the output value of pharmaceutical preparations, the proportion in developed countries can reach 10%-20%, but currently in China, this proportion is only about 2%-3%, which again proves that the golden growth period of China's pharmaceutical excipients industry is far from over.

International giants seize China's pharmaceutical excipients market

The huge development space of China's pharmaceutical excipients market has made international excipient giants covetous. This shows that China's pharmaceutical excipients industry is absolutely not an indispensable medical "supporting role".

With the approaching global wave of expiration of innovative drug patents, generic drugs will enter a period of rapid growth, which will directly lead to a surge in global demand for pharmaceutical excipients in the pharmaceutical preparation market. International pharmaceutical excipient giants are seizing this historical opportunity by expanding the production capacity of existing products and acquiring competitors to add new product lines to achieve rapid expansion, thus sharing the expansion feast of the pharmaceutical adjuvant industry. Currently, international pharmaceutical auxiliary giants have already established production bases and R&D centers in India. Next, they will inevitably target the Chinese pharmaceutical excipients market, which has broad development prospects.